简易三组分临床评分用于多病共存和衰弱老年人的认知风险分层
该横断面研究纳入504名≥65岁孟加拉国社区老年人,开发了一个包含年龄≥80岁、≥3种慢性病和衰弱的三组分评分(0-5分),用于识别认知损害。该评分对认知损害的区分度可接受(AUC=0.72),显著优于仅基于疾病的潜在类别分析表型(AUC=0.44)。
要点
- 三组分评分(年龄≥80岁、≥3种慢性病、衰弱)对认知损害区分度可接受,AUC=0.72。
- 评分风险分级与认知损害患病率呈单调梯度:低危59%、中危83%、高危96%。
- 仅基于疾病的潜在类别分析表型区分度差(AUC=0.44),加入衰弱后AUC modestly升至0.764。
核心结论
- 简易三组分临床评分对多病共存和衰弱老年人的认知损害具有可接受的横断面区分度,并显著优于仅基于疾病的表型分型。
研究设计与样本
- 横断面研究,纳入504名≥65岁、至少一种慢性病的孟加拉国社区居住老年人。
- 衰弱采用Fried表型评估,多病共存为自我报告并按ICD-10编码。
- 开发0-5分 additive 评分(年龄≥80岁、≥3种慢性病、衰弱),分为低危(0-1)、中危(2-3)、高危(4-5)。
- 结局包括整体认知和认知损害(MMSE<25)。
主要发现
- 三组分评分对认知损害的AUC=0.72,解释33%的MMSE方差。
- LCA衍生表型区分度差(AUC=0.44;差异=0.28,p<.001)。
- 认知损害患病率随风险类别单调增加:低危59%、中危83%、高危96%,评分全范围对应MMSE差异12.8分。
- 衰弱增强LCA联合年龄的AUC=0.764,但分析复杂性显著增加。
关键数值与推荐
- 评分组分:年龄≥80岁、≥3种慢性病、衰弱(Fried表型)。
- 风险分层:低危0-1分、中危2-3分、高危4-5分。
- 认知损害定义:MMSE<25。
临床怎么用
- 在资源有限环境中,该简易评分可用于多病共存和衰弱老年人的认知损害病例发现和风险分层。
- 需经前瞻性验证后方可推广应用于临床决策。
局限性
- 横断面设计,无法推断因果或预测性能。
- 结论需前瞻性验证。
- 研究人群为孟加拉国社区老年人,外推性需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Simple, scalable clinical tools are needed to identify older adults with cognitive impairment in low-resource settings, yet whether parsimonious approaches can match complex phenotyping methods remains unclear. This study developed a three-component clinical score and compared its discriminative performance with latent class analysis (LCA)-derived multimorbidity phenotypes. METHODS: This cross-sectional study included 504 Bangladeshi community-dwelling adults aged ≥65 years with at least one chronic disease. Frailty was assessed using the Fried phenotype, and multimorbidity was self-reported and coded using International Classification of Diseases, 10th Revision. An additive score (0-5 points) incorporating age ≥80 years, ≥3 chronic conditions, and frailty classified participants into low (0-1), moderate (2-3), or high (4-5) risk. Outcomes included global cognition and cognitive impairment (Mini-Mental State Examination [MMSE] < 25). RESULTS: The three-component score showed acceptable discrimination for cognitive impairment (area under the curve [AUC] = 0.72) and explained 33% of MMSE variance. LCA-derived phenotypes demonstrated poor discrimination (AUC = 0.44; difference = 0.28, p < .001). A monotonic gradient was observed across risk categories, impairment prevalence increased across risk categories (59%, 83%, and 96%), corresponding to a 12.8-point MMSE difference across the score range. A frailty-augmented LCA (in which frailty was added to the original disease-only LCA) combined with age yielded a modestly higher AUC (0.764), though at substantially greater analytical complexity. CONCLUSIONS: A parsimonious clinical score combining age, multimorbidity, and frailty demonstrated acceptable cross-sectional discrimination for prevalent cognitive impairment and substantially outperformed disease-only multimorbidity phenotyping. Subject to prospective validation, this pragmatic tool may support case-finding and cognitive risk stratification in resource-limited settings.
引用
- Mozid NE, Monju IH, Sharmin S, et al. A pragmatic three-component clinical score for cognitive risk stratification in older adults with multimorbidity and frailty. J Gerontol A Biol Sci Med Sci. 2026. PMID: 42097303. doi:10.1093/gerona/glag117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。